Zydus Lifesciences Gets USFDA Approval for Dasatinib expanding its oncology

Zydus Lifesciences Secures USFDA Approval for Dasatinib Tablets: A Key Growth Opportunity Zydus Lifesciences has received approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Dasatinib…

Sakar Healthcare Ltd Oncology Segment Expansion

1. Sakar Healthcare Ltd Oncology Segment Expansion 2. Penetration into Regulated Markets 3. Export-Driven Growth Strategy 4. Capacity Utilization & Expansion 5. Focus on Margin Improvement 6. Debt Reduction &…